Trestle Biotherapeutics
San Diego
About Trestle Biotherapeutics
Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease. The company's services allow healthcare providers to reduce their reliance on dialysis while also enhancing the disease status of renal patients through the combination of stem cell biology and bio-fabrication. Trestle Biotherapeutics was founded in 2020 by Alice Chen and Ben Shepherd and is based in San Diego, California, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Grant (Jun 2023)
- Website: trestlebio.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/trestle-biotherapeutics-15615 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.